However, there is no consensus on which biomarkers and cut-off values should be used to reliably detect infections in patients with impaired renal function.5 Despite this uncertainty, C-reactive protein (CRP) and procalcitonin are among the most commonly used parameters in clinical follow-up. This evidence concerns the gene CRP and infection.